1. Bashshur ZF, Ma'luf RN, Allam S, et al. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol. 2004; 122:1137–40.
2. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981; 79:371–422.
3. Pe'er J, Folberg R, Itin A, et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology. 1998; 105:412–6.
4. Vinores SA, Youssri Ai, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol. 1997; 12:99–109.
5. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol. 1990; 110:118–23.
Article
6. Magargal LE, Brown GC, Augsburger JJ, Donoso LA. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology. 1982; 89:780–4.
Article
7. Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to central retinal vein occlusion a matched pairs analysis. Ophthalmologica. 2010; 224:126–32.
8. Wu WC, Cheng KC, Wu HJ. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Eye. 2009; 23:2215–22.
Article
9. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion III. Incidence of ocular neovascularization with retinal vein occulusion. Ophthalmology. 1983; 90:488–506.
10. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion study Group M report. Ophthalmology. 1995; 102:1425–33.
11. McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol. 1998; 126:219–29.
Article
12. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc. 2001; 99:219–21.
Article
13. Opremcak EM, Bruce RA, Lomeo M, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina. 2001; 21:408–15.
14. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001; 108:2249–57.
Article
15. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002; 240:782–3.
Article
16. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002; 86:247–8.
Article
17. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol. 2002; 120:1217–9.
Article
18. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004; 122:1131–6.
19. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006; 26:279–84.
20. Schaal KB, Höh AE, Scheuerle A, et al. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmology. 2007; 104:285–9.
21. Choi SW, Kim HW, Yun IH. Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion. J Korean Ophthalmol Soc. 2010; 51:707–15.
Article
22. Shin SG, Ahn JH, Rho SH. A clinical analysis on 456 cases of glaucoma among outpatients during 5 years. J Korean Ophthalmol Soc. 1987; 28:1021–6.
23. Kim DG, Kim HJ, Song MS. Clinical study on glaucomatous patients. J Korean Ophthalmol Soc. 1989; 30:755–9.
24. Song GW, Jin KH, Kim JM. Clinical data on glaucomatous patients. J Korean Ophthalmol Soc. 1990; 31:1179–83.
25. Hwang IC, Jeong SK, Yang KJ. A clinical study on glaucoma. J Korean Ophthalmol Soc. 1992; 33:394–400.
26. Lee CK, Cho YJ, Hong YJ. Distribution of glaucoma outpatients. J Korean Ophthalmol Soc. 1995; 36:1020–7.
27. Lee CH, Jin GH, Kim DM. Clinical analysis on glaucoma. J Korean Ophthalmol Soc. 1998; 39:362–8.
28. Magargal LE, Brown GC, Augsburger JJ, Parrish RK 2nd. Neovascular glaucoma following central retinal vein obstruction. Ophthalmology. 1981; 88:1095–101.
Article
29. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002; 109:920–7.
Article